[1]Campeau,Louis-Charles;Chen,Qinghao;Gauvreau,Danny;Girardin,Mélina;Belyk,Kevin;Maligres,Peter;Zhou,Guoyue;Gu,Chaozhan;Zhang,Wei;Tan,Lushi;O'Shea,PaulD.[OrganicProcessResearchandDevelopment,2016,vol.20,#8,p.1476-1481]
[2]CurrentPatentAssignee:MERCK&COINC-US2011/245296,2011,A1Locationinpatent:Page/Pagecolumn19
[3]Côté,Bernard;Burch,JasonD.;Asante-Appiah,Ernest;Bayly,Chris;Bédard,Leanne;Blouin,Marc;Campeau,Louis-Charles;Cauchon,Elizabeth;Chan,Manuel;Chefson,Amandine;Coulombe,Nathalie;Cromlish,Wanda;Debnath,Smita;Deschênes,Denis;Dupont-Gaudet,Kristina;Falgueyret,Jean-Pierre;Forget,Robert;Gagné,Sébastien;Gauvreau,Danny;Girardin,Melina;Guiral,Sébastien;Langlois,Eric;Li,ChunSing;Nguyen,Natalie;Papp,Rob;Plamondon,Serge;Roy,Amélie;Roy,Stéphanie;Seliniotakis,Ria;St-Onge,Miguel;Ouellet,Stéphane;Tawa,Paul;Truchon,Jean-François;Vacca,Joe;Wrona,Marc;Yan,Youwei;Ducharme,Yves[BioorganicandMedicinalChemistryLetters,2014,vol.24,#3,p.917-922]
[1]CurrentPatentAssignee:MERCK&COINC-US2011/245296,2011,A1
[2]Côté,Bernard;Burch,JasonD.;Asante-Appiah,Ernest;Bayly,Chris;Bédard,Leanne;Blouin,Marc;Campeau,Louis-Charles;Cauchon,Elizabeth;Chan,Manuel;Chefson,Amandine;Coulombe,Nathalie;Cromlish,Wanda;Debnath,Smita;Deschênes,Denis;Dupont-Gaudet,Kristina;Falgueyret,Jean-Pierre;Forget,Robert;Gagné,Sébastien;Gauvreau,Danny;Girardin,Melina;Guiral,Sébastien;Langlois,Eric;Li,ChunSing;Nguyen,Natalie;Papp,Rob;Plamondon,Serge;Roy,Amélie;Roy,Stéphanie;Seliniotakis,Ria;St-Onge,Miguel;Ouellet,Stéphane;Tawa,Paul;Truchon,Jean-François;Vacca,Joe;Wrona,Marc;Yan,Youwei;Ducharme,Yves[BioorganicandMedicinalChemistryLetters,2014,vol.24,#3,p.917-922]
[1]CurrentPatentAssignee:MERCK&COINC-US2011/245296,2011,A1
[2]Campeau,Louis-Charles;Chen,Qinghao;Gauvreau,Danny;Girardin,Mélina;Belyk,Kevin;Maligres,Peter;Zhou,Guoyue;Gu,Chaozhan;Zhang,Wei;Tan,Lushi;O'Shea,PaulD.[OrganicProcessResearchandDevelopment,2016,vol.20,#8,p.1476-1481]
[1]CurrentPatentAssignee:MERCK&COINC-US2011/245296,2011,A1
[2]Campeau,Louis-Charles;Chen,Qinghao;Gauvreau,Danny;Girardin,Mélina;Belyk,Kevin;Maligres,Peter;Zhou,Guoyue;Gu,Chaozhan;Zhang,Wei;Tan,Lushi;O'Shea,PaulD.[OrganicProcessResearchandDevelopment,2016,vol.20,#8,p.1476-1481]
[1]Patent:US2011/245296,2011,A1
[2]Patent:US2011/245296,2011,A1
[3]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.917-922
Title: In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.
Journal: Antimicrobial agents and chemotherapy 20140301
Title: Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.
Journal: Bioorganic & medicinal chemistry letters 20140201
Title: Lai MT et al. In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2014;58(3):1652-63.
Title: Anderson MS et al. Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects. Antivir Ther. 2015;20(4):397-405.
